![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
GlaxoSmithKline plc said on Monday its maintenance therapy for a form of ovarian cancer reduced the risk of disease progression or death by 38% in a late-stage study in cancer patients.
Novartis reports positive Phase 3 PALLADIUM results in uncontrolled asthma
Novartis has announced that its investigational, once-daily, fixed-dose inhaled QMF149 (indacaterol acetate and mometasone furoate) was superior to mometasone furoate (MF) in improving through forced expiratory volume...
MSD’s Keytruda meets primary endpoint in triple-negative breast cancer
MSD have announced results from its Phase 3, KEYNOTE-522 trial that pathological complete response (pCR) in patients with early triple-negative breast cancer significantly increased from 51.2% in the placebo group to 64...
Abbott’s COAPT trial data shows MitraClip device is cost effective, increases life expectancy and improves quality of life
Abbott announced new analyses of the landmark COAPT Trial that show the company’s MitraClip device is cost effective and is projected to increase both life─expectancy and quality of life compared to...
AI system takes 10 seconds to accurately identify key findings in chest X-rays of pneumonia patients
From 20 minutes or more to 10 seconds. Researchers from Intermountain Healthcare and Stanford University say 10 seconds is about how quickly a new system they studied that utilizes artificial intelligence took to...
EMA committee recommends approval of Bristol─Myers Squibb’s new Opdivo dosing regimen
Bristol─Myers Squibb Company announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo (nivolumab) flat dosing schedule of 240 mg...
Abbott’s high sensitivity Troponin─I blood test receives US FDA approval to detect heart attacks faster and accurately
Abbott, announced that its ARCHITECT STAT High Sensitivity Troponin─I blood test has received clearance from the US Food and Drug Administration (FDA). As one of the most researched troponin diagnostic
EMA approves expanded indications to Boehringer Ingelheim’s NexGard, NexGard SPECTRA & Broadline
Boehringer Ingelheim, a world leading animal health company, has received additional marketing authorizations from EMA (European Medicines Agency), broadening the preventative impact of its existing
Abbott’s Proclaim XR recharge─free neurostimulation system receives US FDA approval for people living with chronic pain
Abbott announced the US Food and Drug Administration (FDA) has approved the company’s Proclaim XR recharge─free neurostimulation system for people living with chronic pain.
Roche secures US paediatric approval for Rituxan in two rare forms of vasculitis
Roche has revealed that Rituxan (rituximab), also known as MabThera, has been awarded US approval from the FDA in combination with glucocorticoids for the treatment of granulomatosis with polyangiitis (GPA) or...
Onderzoek: marketeers weten niet waarom ze online video inzetten
Marketeers zetten steeds vaker online video in, maar weten meestal niet waarom ze dat doen. Inmiddels zet 88 procent van de marketeers video in als onderdeel van de marketingmix, maar minder dan de helft (47 procent)...
Loes van Dokkum: ‘We maken teveel van hetzelfde’
Loes van Dokkum is Grand Prix-juryvoorzitter in de categorie Creatie. We spreken haar over het juryproces, verwachtingen en de uitdaging waar de Grand Prix Content Marketing Awards dit jaar voor staat.
Servier on trial for weight-loss pill that led to 2,000 deaths
A trial on one of France’s largest ever healthcare scandals has begun after a weight loss pill was believed to have killed up to 2,000 people, leaving many more injured for life. Pharmaceutical giant Servier is one of...
New discovery may revolutionize treatment of drug-resistant epilepsy
Researchers at Carnegie Mellon University have discovered that the spreading of seizures through the brain can be suppressed depending on the amount of pressure within the brain, an important discovery that may...
Ipsen announces positive phase 3 results in limb spastic hemiparesis
Ipsen has announced results from its ENGAGE study for the combination of Dysport (abobotulinumtoxinA) alongside Guided Self-rehabilitation contracts (GSC) which both improved patients voluntary movement as measured by a...
Astellas’ Xospata scores positive CHMP recommendation
Could become a potential option for hard-to-treat leukaemia
EMA committee recommends approval of GSK’s IV Benlysta in children with lupus aged five years and above
GSK announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the use of intravenous (IV) Benlysta (belimumab)
EMA committee recommends approval of Dupixent for severe chronic rhinosinusitis with nasal polyposis
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent (dupilumab) in a third indication.
